The clearest answer in HIV confirmation testing

When you are confronted with repeatedly reactive HIV screening patient test results it is strongly recommended^1,2,3,4 that you confirm these results with other reliable techniques, such as the INNO-LIA™ HIV I/II Score immunoblot assay.

The INNO-LIA HIV I/II Score test contains recombinant proteins and synthetic peptides from HIV-1 and HIV-2 as well as a synthetic peptide from HIV-1 group O.

These carefully selected antigens are coated at optimal concentrations as discrete lines on a nylon strip with plastic backing.

This immunoblot test detects seroconversion earlier than other confirmation technologies and gives less indeterminate results^5-6.

This reduces the need for repeated testing and thus limiting extra costs.

Compared to other testing technologies the INNO-LIA HIV I/II Score assay provides clear differentiation of HIV-1 and HIV-2 infections^6-7-8 - which allows for much more adequate patient treatment.

 
So, here are some of the key advantages of using our gold standard immunoblot assay for HIV confirmation testing:

• It’s the latest generation of a reference test with more than 25 years of accumulated and widely documented HIV testing results across the world.
• It reliably confirms and differentiates HIV-1, HIV-1 group O, and HIV-2.
• It gives a low number of indeterminate results.
• It comes with ready-to-use and color coded reagents.
• It offers clear cut, standardized and objective reading and interpretation of results.
• It features flexible strip processing with both short and overnight procedures plus efficient walk-away automation; read the results when you are ready.

Download our leaflet for full background information about the characteristics and references of the INNO-LIA Score product range.
 

References:

1. CDC Updated Recommendations for Laboratory Testing for the Diagnosis of HIV infection (published June 27, 2014)
2. Public Health England – UK Standards for Microbiology Investigations / HIV screening and confirmation (Issue date 03.01.17)
3. WHO guidelines – Screening donated blood for Transfusion-Transmissible Infections & Consolidated guidelines on HIV testing Services (July 2015)
4. European guidelines: Guide to the preparation, use and quality assurance of blood components.  Recommendation No.R(95) 15
5. Comparison studies performed at Fujirebio Europe N.V. using BBI seroconversion and low-titer panels.
6. WHO report 16 “HIV ASSAYS: OPERATIONAL CHARACTERISTICS” – 2009
7. Test performance data – IFU INNO-LIA™ HIV I/II Score assay
8. Hønge BL et al. HIV Medicine (2018). The challenge of discriminating between HIV-1, HIV-2 and HIV-1/2 dual infections.